Survival kinases in ischemic preconditioning and postconditioning.

[1]  R. Guyton,et al.  Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. , 2006, Cardiovascular research.

[2]  M. Duchen,et al.  Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. , 2006, The international journal of biochemistry & cell biology.

[3]  J. Downey,et al.  Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. , 2006, American journal of physiology. Heart and circulatory physiology.

[4]  M. Ovize,et al.  PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. , 2006, Cardiovascular research.

[5]  D. Yellon,et al.  Realizing the clinical potential of ischemic preconditioning and postconditioning , 2005, Nature Clinical Practice Cardiovascular Medicine.

[6]  G. Finet,et al.  Postconditioning the Human Heart , 2005, Circulation.

[7]  C. Darling,et al.  Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. , 2005, American journal of physiology. Heart and circulatory physiology.

[8]  R. Bolli,et al.  Role of the Protein Kinase C-&egr;–Raf-1–MEK-1/2–p44/42 MAPK Signaling Cascade in the Activation of Signal Transducers and Activators of Transcription 1 and 3 and Induction of Cyclooxygenase-2 After Ischemic Preconditioning , 2005, Circulation.

[9]  T. Hewett,et al.  Genetic Inhibition or Activation of JNK1/2 Protects the Myocardium from Ischemia-Reperfusion-induced Cell Death in Vivo* , 2005, Journal of Biological Chemistry.

[10]  J. Downey,et al.  Protein Kinase G Transmits the Cardioprotective Signal From Cytosol to Mitochondria , 2005, Circulation research.

[11]  M. Mocanu,et al.  Preconditioning the diabetic heart: the importance of Akt phosphorylation. , 2005, Diabetes.

[12]  R. Guyton,et al.  Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. , 2005, Cardiovascular research.

[13]  J. Daut,et al.  K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. , 2005, Journal of molecular and cellular cardiology.

[14]  L. Opie,et al.  H-89, a Non-Specific Inhibitor of Protein Kinase A, Promotes Post-Ischemic Cardiac Contractile Recovery and Reduces Infarct Size , 2005, Journal of cardiovascular pharmacology.

[15]  J. Downey,et al.  Peptide blockers of PKG inhibit ROS generation by acetylcholine and bradykinin in cardiomyocytes but fail to block protection in the whole heart. , 2005, American journal of physiology. Heart and circulatory physiology.

[16]  M. Mocanu,et al.  Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. , 2005, American journal of physiology. Heart and circulatory physiology.

[17]  D. Yellon,et al.  The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. , 2005, Trends in cardiovascular medicine.

[18]  L. Argaud,et al.  Postconditioning Inhibits Mitochondrial Permeability Transition , 2005, Circulation.

[19]  Michael V. Cohen,et al.  We think we see a pattern emerging here. , 2005, Circulation.

[20]  P. Pagel,et al.  Isoflurane Protects against Myocardial Infarction during Early Reperfusion by Activation of Phosphatidylinositol-3-Kinase Signal Transduction: Evidence for Anesthetic-induced Postconditioning in Rabbits , 2005, Anesthesiology.

[21]  J. Downey,et al.  Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. , 2004, American journal of physiology. Heart and circulatory physiology.

[22]  E. Goetzl,et al.  Sphingosine Kinase Activation Mediates Ischemic Preconditioning in Murine Heart , 2004, Circulation.

[23]  L. Agulló,et al.  Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. , 2004, Cardiovascular research.

[24]  J. Downey,et al.  Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. , 2004, Journal of the American College of Cardiology.

[25]  M. Ashraf,et al.  Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. , 2004, American journal of physiology. Heart and circulatory physiology.

[26]  M. Mocanu,et al.  Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase–Akt Pathway , 2004, Circulation research.

[27]  M. Duchen,et al.  Preconditioning protects by inhibiting the mitochondrial permeability transition. , 2004, American journal of physiology. Heart and circulatory physiology.

[28]  M. Hori,et al.  , Seiji Protein Kinase C Protein Kinase A as Another Mediator of Ischemic Preconditioning Independent of , 2004 .

[29]  N. Maulik,et al.  Role of Akt Signaling in Mitochondrial Survival Pathway Triggered by Hypoxic Preconditioning , 2004, Circulation.

[30]  E. Olson,et al.  Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore , 2004 .

[31]  Chen Yan,et al.  Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion , 2004, FEBS letters.

[32]  Lijun Tang,et al.  Protein kinase C-dependent activation of P44/42 mitogen-activated protein kinase and heat shock protein 70 in signal transduction during hepatocyte ischemic preconditioning. , 2004, World journal of gastroenterology.

[33]  P. Boysen,et al.  Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. , 2004, American journal of physiology. Heart and circulatory physiology.

[34]  B. Berk,et al.  Big Mitogen-Activated Protein Kinase (BMK1)/ERK5 Protects Endothelial Cells From Apoptosis , 2004, Circulation research.

[35]  S. Armstrong.  Protein kinase activation and myocardial ischemia/reperfusion injury. , 2004, Cardiovascular research.

[36]  D. Yellon,et al.  New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. , 2004, Cardiovascular research.

[37]  D. Mochly‐Rosen,et al.  Preservation of Base-line Hemodynamic Function and Loss of Inducible Cardioprotection in Adult Mice Lacking Protein Kinase Cϵ* , 2004, Journal of Biological Chemistry.

[38]  M. Zaugg,et al.  Differential Activation of Mitogen-activated Protein Kinases in Ischemic and Anesthetic Preconditioning , 2004, Anesthesiology.

[39]  W. Schaper,et al.  Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning , 1996, Basic Research in Cardiology.

[40]  E. Iliodromitis,et al.  Alterations in circulating cyclic guanosine monophosphate (c-GMP) during short and long ischemia in preconditioning , 1996, Basic Research in Cardiology.

[41]  E. Hertzberg,et al.  Effects of cGMP-dependent phosphorylation on rat and human connexin43 gap junction channels , 1995, Pflügers Archiv.

[42]  E. Olson,et al.  Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. , 2004, The Journal of clinical investigation.

[43]  J. Downey,et al.  Postconditioning’s protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3–kinase and guanylyl cyclase activation , 2004, Basic Research in Cardiology.

[44]  J. Downey,et al.  Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. , 2004, American journal of physiology. Heart and circulatory physiology.

[45]  Xiuhua Liu,et al.  Hypoxic preconditioning of cardiomyocytes and cardioprotection: phophorylation of HIF-1alpha induced by p42/p44 mitogen-activated protein kinases is involved. , 2003, Pathophysiology : the official journal of the International Society for Pathophysiology.

[46]  G. Dorn,et al.  Additive Protection of the Ischemic Heart Ex Vivo by Combined Treatment With &dgr;-Protein Kinase C Inhibitor and &egr;-Protein Kinase C Activator , 2003 .

[47]  R. Guyton,et al.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.

[48]  G. Semenza,et al.  Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury , 2003, Circulation.

[49]  G. Heusch,et al.  Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  J. Downey,et al.  Acetylcholine-induced production of reactive oxygen species in adult rabbit ventricular myocytes is dependent on phosphatidylinositol 3- and Src-kinase activation and mitochondrial K(ATP) channel opening. , 2003, Journal of molecular and cellular cardiology.

[51]  P. Ping,et al.  Protein Kinase C&egr; Interacts With and Inhibits the Permeability Transition Pore in Cardiac Mitochondria , 2003, Circulation research.

[52]  R. Bolli,et al.  Mechanism of cyclooxygenase-2 upregulation in late preconditioning. , 2003, Journal of molecular and cellular cardiology.

[53]  D. Yellon,et al.  The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. , 2003, Journal of molecular and cellular cardiology.

[54]  J. Downey,et al.  Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals. , 2003, Cardiovascular research.

[55]  R. Bolli,et al.  Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. , 2003, Trends in cardiovascular medicine.

[56]  G. Dorn,et al.  Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. , 2003, Circulation.

[57]  J. Downey,et al.  ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. , 2002, American journal of physiology. Heart and circulatory physiology.

[58]  R. Bolli,et al.  Aldose Reductase Is an Obligatory Mediator of the Late Phase of Ischemic Preconditioning , 2002, Circulation research.

[59]  E. Iliodromitis,et al.  Dissociation of stress-activated protein kinase (p38-MAPK and JNKs) phosphorylation from the protective effect of preconditioning in vivo. , 2002, Journal of molecular and cellular cardiology.

[60]  G. Hunninghake,et al.  Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. , 2002, American journal of physiology. Cell physiology.

[61]  C. Steenbergen.  The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning , 2002, Basic Research in Cardiology.

[62]  D. Yellon,et al.  Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? , 2002, Cardiovascular research.

[63]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[64]  P. Ping,et al.  Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. , 2002, Circulation research.

[65]  J. Weiss,et al.  Protection of cardiac mitochondria by diazoxide and protein kinase C: Implications for ischemic preconditioning , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Baba,et al.  Anti-apoptotic Effect of cGMP in Cultured Astrocytes , 2001, Journal of Biological Chemistry.

[67]  Jimmy D Bell,et al.  α B Crystallin Translocation and Phosphorylation: Signal Transduction Pathways and Preconditioning in the Isolated Rat Heart , 2001 .

[68]  M. Hori,et al.  Cardioprotective Effect Afforded by Transient Exposure to Phosphodiesterase III Inhibitors: The Role of Protein Kinase A and p38 Mitogen-Activated Protein Kinase , 2001, Circulation.

[69]  R. Bolli,et al.  An essential role of the JAK-STAT pathway in ischemic preconditioning , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  W. Ho,et al.  Modulation of ATP-sensitive Potassium Channels by cGMP-dependent Protein Kinase in Rabbit Ventricular Myocytes* , 2001, The Journal of Biological Chemistry.

[71]  A. Lochner,et al.  Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. , 2001, Journal of molecular and cellular cardiology.

[72]  P. Pratt,et al.  Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. , 2001, The Journal of pharmacology and experimental therapeutics.

[73]  M. Shattock,et al.  AlphaB crystallin translocation and phosphorylation: signal transduction pathways and preconditioning in the isolated rat heart. , 2001, Journal of molecular and cellular cardiology.

[74]  Yibin Wang,et al.  The role of differential activation of p38‐mitogen‐activated protein kinase in preconditioned ventricular myocytes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  Jiahuai Han,et al.  PKCε modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes , 2000, American Journal of Physiology-Heart and Circulatory Physiology.

[76]  J. Downey,et al.  Opening of Mitochondrial KATP Channels Triggers the Preconditioned State by Generating Free Radicals , 2000, Circulation research.

[77]  N. Maulik,et al.  SAPKs regulation of ischemic preconditioning. , 2000, American journal of physiology. Heart and circulatory physiology.

[78]  W. Chen,et al.  Ischemic Preconditioning Activates Phosphatidylinositol-3-Kinase Upstream of Protein Kinase C , 2000, Circulation research.

[79]  P. Ping,et al.  Role of p38 mitogen-activated protein kinases in preconditioning: a detrimental factor or a protective kinase? , 2000, Circulation research.

[80]  Z. Gu,et al.  Diphosphorylation of extracellular signal-regulated kinases and c-Jun N-terminal protein kinases in brain ischemic tolerance in rat , 2000, Brain Research.

[81]  T. Vanden Hoek,et al.  Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. , 2000, Circulation research.

[82]  J. Downey,et al.  Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. , 2000, Circulation research.

[83]  P. Ping,et al.  PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. , 2000, American journal of physiology. Heart and circulatory physiology.

[84]  Y. Takeishi,et al.  Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts. , 1999, Circulation research.

[85]  M. Matsuzaki,et al.  Ischemic preconditioning attenuates apoptosis through protein kinase C in rat hearts. , 1999, American journal of physiology. Heart and circulatory physiology.

[86]  Jiahuai Han,et al.  PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. , 1999, American journal of physiology. Heart and circulatory physiology.

[87]  P. Ping,et al.  Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. , 1999, Circulation research.

[88]  A. Lochner,et al.  Ischemic Preconditioning and the β-Adrenergic Signal Transduction Pathway , 1999 .

[89]  M. Ashraf,et al.  Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium. , 1999, Circulation research.

[90]  P. Ping,et al.  PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. , 1999, American journal of physiology. Heart and circulatory physiology.

[91]  P. Ping,et al.  Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. , 1999, Circulation research.

[92]  C. Ganote,et al.  Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. , 1999, Journal of molecular and cellular cardiology.

[93]  P. Ping,et al.  PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. , 1999, The American journal of physiology.

[94]  C. Widmann,et al.  Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. , 1999, Physiological reviews.

[95]  A. Lochner,et al.  Ischemic preconditioning and the beta-adrenergic signal transduction pathway. , 1999, Circulation.

[96]  A. Clerk,et al.  Activation of mitogen‐activated protein kinases (p38‐MAPKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart , 1998, FEBS letters.

[97]  J. Cleveland,et al.  Mechanisms of pH preservation during global ischemia in preconditioned rat heart: roles for PKC and NHE. , 1998, American journal of physiology. Heart and circulatory physiology.

[98]  E. Marbán,et al.  Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. , 1998, Circulation research.

[99]  Shuang Huang,et al.  Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[100]  A. Clerk,et al.  The p38‐MAPK inhibitor, SB203580, inhibits cardiac stress‐activated protein kinases/c‐Jun N‐terminal kinases (SAPKs/JNKs) , 1998, FEBS letters.

[101]  G. Heusch,et al.  Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. , 1998, Journal of molecular and cellular cardiology.

[102]  Role of protein kinase C-alpha in activation of ecto-5'-nucleotidase in the preconditioned canine myocardium. , 1997, Biochemical and biophysical research communications.

[103]  P. Ursell,et al.  Ischemic preconditioning decreases apoptosis in rat hearts in vivo. , 1997, Circulation.

[104]  J. Downey,et al.  Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. , 1997, Journal of molecular and cellular cardiology.

[105]  P. Ping,et al.  Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. , 1997, Circulation research.

[106]  M. Kitakaze,et al.  Implication of protein kinase C-alpha, delta, and epsilon isoforms in ischemic preconditioning in perfused rat hearts. , 1997, Journal of biochemistry.

[107]  G. Baxter,et al.  Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. , 1997, Journal of molecular and cellular cardiology.

[108]  J. Downey,et al.  Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. , 1997, Journal of molecular and cellular cardiology.

[109]  N. Maulik,et al.  Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts , 1996, FEBS letters.

[110]  G. Brooks,et al.  Role of protein kinase C in ischemic preconditioning: player or spectator? , 1996, Circulation research.

[111]  S. Nattel,et al.  Protein kinase C activates ATP-sensitive K+ current in human and rabbit ventricular myocytes. , 1996, Circulation research.

[112]  D. Buxton,et al.  Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. , 1996, Biochemical and biophysical research communications.

[113]  J. Downey,et al.  Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. , 1995, Circulation research.

[114]  D. Yellon,et al.  Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium , 1995, British journal of pharmacology.

[115]  E. Krebs,et al.  Inactivation of Glycogen Synthase Kinase-3 by Epidermal Growth Factor Is Mediated by Mitogen-activated Protein Kinase/p90 Ribosomal Protein S6 Kinase Signaling Pathway in NIH/3T3 Cells (*) , 1995, The Journal of Biological Chemistry.

[116]  Michel Morange,et al.  A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins , 1994, Cell.

[117]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[118]  J. Downey,et al.  Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. , 1994, Journal of molecular and cellular cardiology.

[119]  J. Downey,et al.  Preconditioning protects ischemic rabbit heart by protein kinase C activation. , 1994, The American journal of physiology.

[120]  J. Downey,et al.  Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. , 1994, Cardiovascular research.

[121]  C. Slaughter,et al.  An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. , 1990, Science.

[122]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[123]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .